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abstract
 
Extracellular ATP regulates several elements of the mucus clearance process important for pulmonary
host defense. However, the mechanisms mediating ATP release onto airway surfaces remain unknown. Mitochondrial
voltage-dependent anion channels (mt-VDACs) translocate a variety of metabolites, including ATP and ADP,
across the mitochondrial outer membrane, and a plasmalemmal splice variant (pl-VDAC-1) has been proposed to
mediate ATP translocation across the plasma membrane. We tested the involvement of VDAC-1 in ATP release in
a series of studies in murine cells. First, the full-length coding sequence was cloned from a mouse airway epithelial
cell line (MTE7b
 
 
 
) and transfected into NIH 3T3 cells, and pl-VDAC-1-transfected cells exhibited higher rates of
ATP release in response to medium change compared with mock-transfected cells. Second, ATP release was
compared in cells isolated from VDAC-1 knockout [VDAC-1 (
 
 
 
/
 
 
 
)] and wild-type (WT) mice. Fibroblasts from
VDAC-1 (
 
 
 
/
 
 
 
) mice released less ATP than WT mice in response to a medium change. Well-differentiated cultures
from nasal and tracheal epithelia of VDAC-1 (
 
 
 
/
 
 
 
) mice exhibited less ATP release in response to luminal
hypotonic challenge than WT mice. Confocal microscopy studies revealed that cell volume acutely increased in
airway epithelia from both VDAC-1 (
 
 
 
/
 
 
 
) and WT mice after luminal hypotonic challenge, but VDAC-1 (
 
 
 
/
 
 
 
)
cells exhibited a slower regulatory volume decrease (RVD) than WT cells. Addition of ATP or apyrase to the luminal
surface of VDAC-1 (
 
 
 
/
 
 
 
) or WT cultures with hypotonic challenge produced similar initial cell height responses
and RVD kinetics in both cell types, suggesting that involvement of VDAC-1 in RVD is through ATP release. Taken
together, these studies suggest that VDAC-1, directly or indirectly, contributes to ATP release from murine cells.
However, the observation that VDAC-1 knockout cells released a signiﬁcant amount of ATP suggests that other
molecules also play a role in this function.
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INTRODUCTION
 
Extracellular ATP acts as a signaling molecule in an
autocrine fashion in a wide variety of cells (Dubyak and
el-Moatassim, 1993; Ralevic and Burnstock, 1998), includ-
ing airway epithelial cells. Physiologic, noncytolytic release
of ATP from cells in response to mechanical stress
(Grygorczyk and Hanrahan, 1997; Watt et al., 1998;
Homolya et al., 2000) or hypotonic challenge (Wang et
al., 1996b; Hazama et al., 1999) is well documented. In
airway epithelia, released ATP acts through purinergic
receptors (P2Y
 
2
 
 receptors) to initiate phospholipase
C–mediated increases in intracellular Ca
 
2
 
 
 
 and diacyl-
glycerol-mediated activation of protein kinase C. These
actions promote Cl
 
 
 
 secretion via Ca
 
2
 
 
 
-activated Cl
 
 
 
channels (Clarke et al., 1992) and CFTR (Jia et al., 1997),
inhibit amiloride-sensitive epithelial Na
 
 
 
 absorption (Mall
et al., 2000), increase ciliary beat frequency (Geary et al.,
1995), and stimulate mucin release (Davis et al., 1992;
Lethem et al., 1993). Extracellular ATP is broken down
by a complex array of hydrolytic activities, and aden-
osine, the ﬁnal product of ATP metabolism, promotes
cAMP-regulated CFTR activity via A2b adenosine recep-
tors (Huang et al., 2001). Whereas the roles of ATP and
adenosine in modulating the integrated actions of
mucociliary clearance important for pulmonary host
defense have been elucidated, it is still largely unknown
how ATP reaches the airway epithelial cell surface.
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VDAC and ATP Release
 
In general terms, the physiologic release of ATP into
the extracellular environment has been postulated to be
mediated by vesicular release or channels. In addition to
ATP release by regulated exocytosis from excitatory
or secretory tissues such as neurons, chromafﬁn cells,
platelets, and mast cells (Burnstock, 1997), vesicular
transport of ATP has been reported recently also in non-
excitatory tissues such as endothelial cells (Bodin and
Burnstock, 2001), intestinal 407 cells (van der Wijk et
al., 2003), urothelial cells (Knight et al., 2002), and bil-
iary cells (Gatof et al., 2004). Channel-mediated mecha-
nisms have included ATP binding cassette (ABC) trans-
porters including CFTR (Reisin et al., 1994; Schwiebert
et al., 1995) and the multiple drug resistance (MDR)
protein (Roman et al., 2001), connexin hemichannels
(Cotrina et al., 1998), maxi-anion channels (Sabirov et
al., 2001; Bell et al., 2003), and stretch-activated chan-
nels (Caldwell et al., 1998; Braunstein et al., 2001).
Voltage-dependent anion channels (VDACs) are pore-
forming proteins (porins) in the mitochondrial outer
membrane, where they represent 5% of the total pro-
tein (rat liver mitochondria; Linden et al., 1984), and
transport a variety of purine nucleotides, including
ATP and ADP (Rostovtseva and Colombini, 1996). At
physiological pH, most intracellular ATP molecules ex-
ist in anionic forms (MgATP
 
2
 
 
 
). It is, therefore, possi-
ble that anion channels can conduct ATP across the
plasma membrane, similar to the VDAC function in the
mitochondrial outer membrane. Recent electrophysio-
logical studies have suggested that “VDAC-like” maxi
(large conductance)-anion channels are detected in
the plasma membranes of Chinese hamster ovary cells
(Mangel et al., 1993), rat bile duct epithelial cells (Mc-
Gill et al., 1993), rabbit renal cortical collecting duct
cells (Light et al., 1990; Schwiebert et al., 1994), HeLa
cells (Schwarzer et al., 2000), and bovine brain astro-
cytes (Dermietzel et al., 1994; Guibert et al., 1998). More-
over, hypotonicity-induced ATP release through vol-
ume-sensitive anion channels has been reported in
bovine aortic endothelial cells (Hisadome et al., 2002),
mouse mammary carcinoma (C127i) cells (Sabirov et
al., 2001), and in rabbit macula densa cells (Bell et al.,
2003). Collectively, these results suggest that plasma-
lemmal VDAC-like maxi-anion channels could conduct
ATP in response to physiologic stresses.
Whether VDAC itself mediates plasmalemmal maxi-
anion channel activity, however, remains controversial.
Linden et al. (1984) demonstrated the exclusive local-
ization of rat liver VDAC in the mitochondrial outer
membrane by subcellular fractionation and immuno-
blotting techniques using monospeciﬁc antisera against
the porin isolated from the outer membrane of rat liver
mitochondria. Several subsequent studies reported ex-
tramitochondrial locations of VDAC, mostly by immu-
nocytochemical techniques (Cole et al., 1992; Dermiet-
zel et al., 1994; Jakob et al., 1995). However, the po-
tential for artifactual localization of VDAC in plasma
membrane in those studies, such as nonspeciﬁc bind-
ing of antibodies or protein redistribution during the
fractionation of cellular membranes, was raised by Yu et
al. (1995) (Yu and Forte, 1996). Indeed, Yu et al. dem-
onstrated that FLAG-tagged VDAC-1 protein overex-
pressed in COS cells was exclusively localized to mito-
chondria by immunoelectron microscopy. Of note,
more recently, VDAC-1 protein was isolated from caveo-
lae-like domains of biotinylated plasma membrane frac-
tions by biochemical techniques and exhibited similar
properties as those of mitochondrial porin in planar bi-
layers (Bathori et al., 1999). Furthermore, a splice vari-
ant of the mitochondrial VDAC-1 (mt-VDAC-1) gene,
which encodes a leader peptide of 13 amino acids at
NH
 
2
 
 terminus, was isolated from a murine brain cDNA
library by 5
 
 
 
-RACE-PCR (Buettner et al., 2000). The
protein from this splice variant exhibited extramito-
chondrial trafﬁcking to the endoplasmic reticulum,
the  Golgi apparatus, and possibly the plasma mem-
brane, and thus was named plasmalemmal VDAC-1 (pl-
VDAC-1). Antisense oligonucleotides directed against
the speciﬁc membrane leader sequence of pl-VDAC-1
markedly reduced both plasmalemmal VDAC immuno-
staining and maxi Cl
 
 
 
 currents in C1300 mouse neuro-
blastoma cells (Bahamonde et al., 2003). In sum, it
remains unclear whether VDAC participates in ATP re-
lease and whether such activity may require plasma
membrane localization.
Accordingly, in the present study, our primary goal
was to test the simplest hypothesis, i.e., whether VDAC is
associated with physiologically signiﬁcant extracellu-
lar ATP release, before initiating studies on its mecha-
nism and site of action. Thus, we transfected pl-VDAC-1
cDNA in NIH 3T3 cells and tested whether transfection
affected release of ATP from the intracellular to exter-
nal environment. Subsequent studies focused on pri-
mary ﬁbroblasts and airway cells from mice in which the
VDAC-1 gene was disrupted by gene targeting (Anﬂous
et al., 2001). We investigated the ATP release properties
of these cells and the contribution of VDAC-1 to ATP re-
lease–mediated airway epithelial cell volume regulation
in response to luminal hypotonic challenge.
 
MATERIALS AND METHODS
 
Cloning of Full-length pl-VDAC-1 Coding Sequence
 
Primers designed to amplify the full-length pl-VDAC-1 were as
follows: forward primer, VD-F, 5
 
 
 
-aga gaa ttc cac cat gtg ttc att ctt
tct cgt gct t-3
 
 
 
; reverse primer, VD-R, 5
 
 
 
-gtg tgg atc cgc tta tgc
ttg aaa ttc cag tcc tag gcc aag-3
 
 
 
 (Fig. 1 A). Total RNA was pre-
pared from an immortalized mouse tracheal epithelial cell line
(MTE7b
 
 
 
; Thomas et al., 2000) using an RNAeasy kit (QIAGEN)
and reverse transcribed with random primers using Superscript
II (Invitrogen). The resulting cDNA was used as a template, and 
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PCR was performed using high ﬁdelity PFU enzyme (Promega)
according to the following protocol: 94
 
 
 
C 2 min, 5 cycles of 94
 
 
 
C
45 s–58
 
 
 
C 45 s–72
 
 
 
C 1 min, 35 cycles of 94
 
 
 
C 45 s–65
 
 
 
C 45 s–72
 
 
 
C
1 min, and 72
 
 
 
C 5 min.
The full-length pl-VDAC-1 cDNA was cloned into pCR-Blunt II-
TOPO (Invitrogen). A pl-VDAC-1 cDNA was also constructed
that contained the c-myc tag (A-S-M-Q-K-L-I-S-E-D-L) on the
COOH terminus (pl-VDAC-1-myc) by the addition of the c-myc
tag sequence to the reverse primer (VD-myc-R, 5
 
 
 
-gtg tgg atc cgc
tta cag gtc ctc ctc tga gat cag ctt ctg cat tga tgc tgc ttg aaa ttc cag
tcc tag gcc aag-3
 
 
 
) and ampliﬁcation with the same protocol as
above. Both constructs were subsequently cloned into a retroviral
expression plasmid with a puromycin-resistant cassette (pLXPIP;
Olsen et al., 1992) for vector production.
 
Overexpression of pl-VDAC-1 in NIH 3T3 Cells
 
Mouse NIH 3T3 cells were grown in Dulbecco’s modiﬁed eagles
medium (DMEM) with 10% FBS and penicillin/streptomycin.
To transfect NIH 3T3 cells with retroviral vectors, cells were
seeded at 2.5 
 
 
 
 10
 
5
 
 cells per 35-mm dish. Retroviruses carrying
pl-VDAC-1 or pl-VDAC-1-myc, or viruses produced from pLXPIP
without gene insert (“mock” viruses), were added to cells (10
 
5
 
 in-
fectious units/ml, 1 ml/plate) and incubated with polybrene (8
 
 
 
g/ml) for 2 h at 37
 
 
 
C. Virus-containing medium was subse-
quently replaced with fresh medium. Selection with puromycin
(5 
 
 
 
g/ml) was initiated 24 h after the removal of virus and was
continued for a week.
To establish clonal cell lines, cells from virally transfected pop-
ulations were trypsinized and plated in serial dilutions in 96-well
plates. Wells that yielded a colony from a single cell were selected
and expanded. A 25-mm
 
2
 
 ﬂask with conﬂuent cells was obtained
 
 
 
3 wk after the plating of single cells.
 
Primary Culture Preparation from WT, VDAC-1 (
 
 
 
/
 
 
 
), 
and FOXJ1/EGFP Transgenic Mice
 
Lung ﬁbroblasts were isolated from wild-type (WT) and VDAC-1
(
 
 
 
/
 
 
 
) mice as previously published (Homolya et al., 1999) from
explant cultures. Outgrown ﬁbroblasts were trypsinized and pas-
saged in 25-cm
 
2
 
 ﬂasks (Falcon).
Primary cultures of tracheal and nasal epithelial tissue were gen-
erated from WT, VDAC-1 (
 
 
 
/
 
 
 
), and FOXJ1/EGFP transgenic
mice (Ostrowski et al., 2003) with a protocol modiﬁed based on a
previous report (You et al., 2002). VDAC-1 (
 
 
 
/
 
 
 
) mice and their
WT littermate controls (CD1 background), or FOXJ1/EGFP trans-
genic mice (C3H x C57B1/6J F1 background), were killed at 4–8
wk of age. Resected tracheal and nasal tissues were incubated sepa-
rately in Ham’s F-12 containing 1.5 mg/ml pronase (Roche Molec-
ular Biochemicals) for 4 h at 4
 
 
 
C with vigorous shaking every 30
min. Isolated cells were resuspended (100 
 
 
 
l/trachea and 500 
 
 
 
l/
nose) in METC/Plus media (You et al., 2002). Yields were 
 
 
 
2.0 
 
 
 
10
 
5
 
 cells/trachea and 
 
 
 
5.0 
 
 
 
 10
 
5
 
 cells/nose from a 15–20-g
mouse. Harvested cells (1.5 
 
 
 
 10
 
5
 
 cells/cm
 
2
 
) were seeded on
6.5-mm collagen-coated transwells (0.4 
 
 
 
m pore diameter; Corn-
ing-Costar) and incubated with MTEC/Plus media in both
chambers. After the transmembrane resistance (R
 
t
 
) exceeded 1,000
Ohms.cm
 
2
 
 (EVOM; World Precision Instruments), medium was re-
moved from the upper chamber to establish an air–liquid inter-
face. Cultures were studied in the fully differentiated state 3–4 wk
after seeding. All cultures were maintained at 37
 
 
 
C in a humidiﬁed
incubator supplemented with 5% CO
 
2
 
.
 
Expression Analysis of pl-VDAC-1 and mt-VDAC-1
 
Primers were designed to test for mRNA expression of pl-VDAC-1
(f-pl and r), pl-VDAC-1-myc (f-myc and myc-r), and mt-VDAC-1
(f-mt and r) in pl-VDAC-1–transduced 3T3 cells and primary
mouse cultures: f-pl, 5
 
 
 
-tgt gtt cat tct ttc tcg tgc-3
 
 
 
; r, 5
 
 
 
-cca gtg ttc
ggc gag aat gac-3
 
 
 
; f-myc, 5
 
 
 
-ctt cgg aat agc caa-3
 
 
 
; myc-r, 5
 
 
 
-ag ctt
ctg cat tga tgc t-3
 
 
 
; f-mt, 5
 
 
 
-gct gct ccc gcc gtc acc gcc-3
 
 
 
 (Fig. 1 A).
Total RNA prepared from mock- and pl-VDAC-1–transfected
NIH 3T3 cells and cultures from WT and VDAC-1 (
 
 
 
/
 
 
 
) mice
was reverse transcribed as described above. PCR was performed
according to the following protocol: 94
 
 
 
C 7 min, 35 cycles of
94
 
 
 
C 30 s–55
 
 
 
C 30 s–72
 
 
 
C 30 s, and 72
 
 
 
C 7 min. For each cDNA
pool, cyclophilin B mRNA expression was studied as a house-
keeping mRNA control.
 
Incubations and Sample Collection
 
Fibroblasts.
 
Fibroblasts were seeded on 10 mm diameter wells of
24-well plates and grown to near conﬂuence (
 
 
 
90%) in DMEM
supplemented with 10% FBS and penicillin/streptomycin. Cul-
tures were rinsed and preincubated with 300 
 
 
 
l serum-free
DMEM for 1 h, and aliquots of 100 
 
 
 
l gently removed (
 
 
 
100 
 
 
 
l/s)
to determine basal ATP concentrations. For the mechanical stim-
ulation (medium change) studies, the remaining medium was
gently aspirated and prewarmed new medium (300 
 
 
 
l) added
(
 
 
 
100 
 
 
 
l/s). 30-
 
 
 
l samples were obtained at each indicated sam-
pling interval. Each sample was immediately placed on ice,
heated to 98
 
 
 
C for 2 min, and stored at 
 
 
 
20
 
 
 
C. To measure intra-
cellular ATP, cells were lysed with 0.5 ml ice-cold 5% trichloro-
acetic acid (TCA), extracted three times with 6
 
 
 
 volume ethyl
ether, and the samples were stored at 
 
 
 
20
 
 
 
C until assaying for
ATP levels as described below.
 
Airway Epithelial Cultures.
 
Polarized airway epithelial cultures
on transwells were rinsed bilaterally with PBS and incubated with
120  l Hank’s balanced salt solution (HBSS) on the basolateral
and 30  l HBSS on the apical surface for 1 h at 37 C to establish
basal conditions for ATP release. Cultures were gently placed
onto the microsampling stage (Lazarowski et al., 2004) and equil-
ibrated for 10 min. For measurement of apical steady-state ATP
levels, 10- l samples were obtained with a capillary (World Preci-
sion Instruments, 1.0 mm diameter) interfaced to a microscope-
mounted micromanipulator. Basolateral samples (20  l) were
collected using gel loading tips. Then, 10  l H2O or 10  l 300
mOsm mannitol was gently added to the mucosal compartment
to generate an apical 200 mOsm or an isosmotic control solu-
tion, respectively. 2 and 10 min later, samples from apical surface
(15  l) and from basolateral bath (20  l) were obtained and pro-
cessed as described above. Airway epithelial intracellular ATP was
extracted as described above.
Luciferin/Luciferase ATP Assay
The luciferin–luciferase assay was performed as described previ-
ously (Watt et al., 1998). In brief, 3–30- l aliquots from each sam-
ple were added to test tubes containing 300  l H2O. The tubes
were placed in the light chamber of an LB953 AutoLumat lumi-
nometer (Berthold GmbH), and a luciferin–luciferase cocktail
(luciferin 80  g/ml and luciferase 4  M, 100  l/assay) was
added to each sample with a built-in injector. Luminescence was
recorded for 10 s and compared with an ATP calibration curve
performed in parallel.
Derivatization of Adenyl Purines
Adenine nucleotides/nucleosides were derivatized to ﬂuorescent
1, N6-ethenopurines by reaction with 1.0 M 2-chloroacetaldehyde
25 mM Na2HPO4 (pH 4.0) and analyzed by HPLC (Waters
717plus Autosampler HPLC) as described previously (Huang et
al., 2001; Lazarowski et al., 2004).516 VDAC and ATP Release
Cell Viability Assay
A calcein and ethidium homodimer–based assay was employed to
test cell viability using LIVE/DEAD viability/cytotoxicity kit (Mo-
lecular Probes, Inc.) according to the manufacturer’s instruc-
tions. The number of dead cells amongst 500 cells was counted
before and after medium change in mock- and pl-VDAC-1–trans-
fected cells.
Confocal Microscopy Assessment of Cellular Volume Regulation
Well-differentiated cultures from VDAC-1 ( / ) and WT mice
were loaded bilaterally with 5  M calcein-AM (Molecular
Probes, Inc.) for 30 min at 37 C. These cultures, as well as cul-
tures from FOXJ1/EGFP mice, were equilibrated for 10 min
with 20  l of Krebs-bicarbonate ringer (KBR) on the apical sur-
face and 5  l of KBR on the basolateral surface before study.
They were then analyzed by a confocal ﬂuorescence micro-
scope (model 510, PL APO 40 /1.20 mm water lens; Carl Zeiss
MicroImaging, Inc.) by placing the culture on a 25 mm cover-
slip that formed the bottom of an open chamber. H2O (10  l)
was added to apical surface to generate a 200 mOsm solution,
and xz-scanning images were obtained every 3 s for 30 s. Analy-
ses of EGFP expression in FOXJ1/EGFP cultures revealed that
the cultures were pseudo-stratiﬁed, i.e., the lumen-facing cul-
tured cells extended to the Transwell membrane. This distance
was equivalent to the distance from the apex of the lumen-fac-
ing cells to the Transwell membrane in the calcein-AM–loaded
WT and VDAC-1 ( / ) cultures. Accordingly, the distance be-
tween the apex of the lumen-facing cells and the Transwell
membrane was deﬁned as luminal cell height, and distances be-
fore and after addition of H2O were quantitated with Meta-
morph software (three measurements per image). Experiments
were also performed on cultures by exposing them to ATP (100
 M in 10  l H2O) or apyrase (10 U/ml in 10  l H2O) as com-
pared with H2O alone (10  l).
Statistical Analysis
Data were expressed as mean values   SEM of observations.
Where appropriate, data were analyzed by paired Student’s un-
paired t test (to compare two unpaired groups of measurement
data) with Statview software, and statistical signiﬁcance was de-
ﬁned as P   0.05.
RESULTS
Overexpression of pl-VDAC-1 in NIH 3T3 Cells
The full-length pl-VDAC-1 cDNA (0.9 kb) was am-
pliﬁed from a mouse tracheal epithelial cell line
(MTE7b ) by RT-PCR and veriﬁed by sequencing. Pl-
VDAC-1 and pl-VDAC-1-myc, cloned into pLXPIP retro-
viral vectors, were transfected into NIH 3T3 cells. 14 d
after transfection, pl-VDAC-1 expression was evaluated
by RT-PCR (Fig. 1 B). Endogenous pl-VDAC-1 mRNA
was detected in mock-transfected NIH 3T3 cells, and
increased pl-VDAC-1 levels were observed in pl-VDAC-
1–transfected cells.
Pl-VDAC-1–transfected cells exhibited greater extra-
cellular ATP accumulation after a medium change rela-
tive to mock-transfected cells 14 d after transfection
(Fig. 2 A). Basal extracellular ATP levels, however, were
similar in both groups. As a measure of extracellular
ATP metabolism, exogenous ATP decayed at a similar
rate in both groups (from 200 nM at t   0 to 105.2  
4.3 nM in mock- and 101.7   3.6 nM in pl-VDAC-1–
transfected cells 2 h later, n   4). Intracellular ATP lev-
els were also not signiﬁcantly different between the two
groups (9.3   0.2 and 9.6   0.2 nmol/million cells in
pl-VDAC-1- and mock-transfected cells, respectively,
n   4). Cell viability, as measured by calcein and ethid-
ium homodimer–based assays, did not differ signiﬁ-
cantly between groups before or after the medium
change: the percentage of dead cells was 0.35   0.11%
before medium change and 0.45   0.15% after me-
dium change in mock-transfected cells, and 0.25  
Figure 1. Schematic of mt-VDAC-1
and pl-VDAC-1 genomic regions and
expression analysis of pl-VDAC-1
mRNA. (A) In the genomic schema,
boxes indicate exons and T stands for
transcription start site. The leader se-
quence in pl-VDAC-1 is encoded by
Exon 1a/2 as indicated. Primers VD-F
and VD-R were designed to detect
the presence of full-length pl-VDAC-1
mRNA; VD-F was designed to hybridize
speciﬁcally to pl-VDAC-1 sequence and
not to mt-VDAC-1. VD-R hybridized 3 
to the translation termination codon. Primers f-pl and r, f-2 and myc-r, and f-mt
(and r) were designed to amplify pl-VDAC-1, pl-VDAC-1-myc, and mt-VDAC-1,
respectively. (B) Top, expression of total (endogenous and exogenous) pl-VDAC-1;
middle, exogenous pl-VDAC-1-myc; bottom, cyclophilin B mRNA in mock- and
pl-VDAC-1-myc–transfected NIH 3T3 cells 14 d after transfection. In each lane
from left to right, molecular weight markers (MW), and pl-VDAC-1-myc–trans-
fected (VD) and mock-transfected (mock) cell cDNAs were loaded. Top, primers
f-pl and r, predicted size of pl-VDAC-1   420 bp; middle, primers f-myc and myc-r,
predicted size of pl-VDAC-1-myc   250 bp; bottom, cyclophilin B primers,
predicted size   200 bp.517 Okada et al.
0.11% before medium change and 0.35   0.11% after
medium change in pl-VDAC-1–transfected cells (mean  
SEM of four separate experiments). These ﬁndings in-
dicate that the greater extracellular ATP accumulation
in pl-VDAC-1–transfected cells did not reﬂect differ-
ences in extracellular ATP metabolism, intracellular
ATP levels, or cell lysis, but rather an increased rate of
ATP release.
A persistent problem with pl-VDAC-1 overexpres-
sion studies has been selection against pl-VDAC-1 ex-
pression (Buettner et al., 2000). To test whether such
a phenomenon existed in pl-VDAC-1–transfected NIH
3T3 cells, we measured extracellular ATP levels after
medium change and pl-VDAC-1-myc protein expres-
sion in pl-VDAC-1-myc–transfected cells 14 and 35 d
after transfection. As compared with measurements
14 d after transfection, decreased extracellular ATP
accumulation and pl-VDAC-1-myc protein expression
were observed in cells 35 d after transfection (Fig. 2
B). As above, pl-VDAC-1-myc–transfected cells exhib-
ited similar extracellular ATP hydrolysis rates (from
200 nM at t   0 to 103.7   3.8 nM 14 d after transfec-
tion and 105.1   3.5 nM 35 d after transfection 2 h
later, n   4), intracellular ATP levels (9.7   0.3 and
9.5   0.3 nmol/million cells 14 and 35 d after trans-
fection, respectively, n   4), and cell viability (0.31  
0.13% before medium change and 0.42   0.15% after
medium change, n    4) as mock-transfected cells.
These results suggest that changes in pl-VDAC-1 ex-
pression correlate with medium change–induced ex-
tracellular ATP levels.
Because of the possible bias in comparing heteroge-
neous pools of puromycin–selected cells, clonal cell
populations were isolated and established from mock-
or pl-VDAC-1-myc–transfected cells. ATP release lev-
els varied between pl-VDAC-1-myc–transfected clones,
which may be due to the variability in pl-VDAC-1
expression levels. The mean value of ATP release lev-
els  from pl-VDAC-1-myc–transfected clones exceeded
those of mock-transfected clones in response to a me-
dium change (11 clones from each group; Fig. 2 C),
consistent with results from heterogeneous populations
shortly after transfection (Fig. 2 A). 9 out of 11 pl-
VDAC-1-myc–transfected clones exhibited signiﬁcantly
higher ATP levels (ranging from 150 to 420%) com-
pared with the average of mock-transfected clones. In-
tracellular ATP and basal extracellular ATP levels were
not different between these two groups.
Figure 2. ATP release from mock
(empty virus)- and pl-VDAC-1–trans-
fected NIH 3T3 cells in response to
medium change. (A) 14 d after transfec-
tion by retroviral vectors and puromy-
cin selection, heterogenous populations
of mock-transfected ( ) or pl-VDAC-1–
transfected ( ) NIH 3T3 cells were
studied for ATP release. After medium
change, extracellular medium was col-
lected at each indicated time and ATP
was measured by luminometry (n   4).
* indicates signiﬁcant difference be-
tween pl-VDAC-1– and mock-trans-
fected, P   0.05. (B) ATP release
properties after medium change and
expression levels of transfected protein
in pl-VDAC-1-myc–transfected cells.
(Left) ATP levels were measured from
mock- and pl-VDAC-1-myc–transfected
cells 14 and 35 d after transfection with
the same protocol used in A (n   4). †,
‡, and * indicate signiﬁcant differences
(P   0.05) between mock- and pl-VDAC-
myc (14 d after) transfection, pl-VDAC-
1-myc (14 d after) and pl-VDAC-1-myc
(35 d after) transfection, and mock and
pl-VDAC-1-myc (35 d after) transfection,
respectively. (Right) Western blots of exogenous pl-VDAC-1-myc expression. In top panel, whole cell lysates (30  g/lane) were probed
with an anti-myc tag rabbit polyclonal antibody and an HRP-conjugated goat anti-rabbit IgG. Bottom panel is anti– -tubulin as a marker of
total protein loading. A band of the expected size of  39 kD was detected only in pl-VDAC-1-myc–transfected cells. The band had a higher
intensity 14 d after transfection compared with 35 d after transfection. (C) ATP release from mock- or pl-VDAC-1–transfected clonal
cell populations. Bars represent the mean values of extracellular ATP, 2 min after medium change for 11 clones/group. The data were
normalized for intracellular ATP as follows: extracellular ATP (mol) in bulk medium/intracellular ATP (mol) per well   1,000 (n   4).
* indicates signiﬁcant difference (P   0.05) between mock- and pl-VDAC-1-myc–transfected clones.518 VDAC and ATP Release
VDAC-1 Expression in Tissues from VDAC-1 ( / ) 
and WT Mice
By using designed primers (Fig. 1 A), we conﬁrmed
by RT-PCR that WT mice expressed both mt- and pl-
VDAC-1 mRNA in nasal and tracheal epithelial cultures
and in lung ﬁbroblasts, whereas cells from VDAC-1 ( / )
mice exhibited neither VDAC transcript (Fig. 3).
ATP Release from VDAC-1 ( / ) and WT Fibroblasts
Both VDAC-1 ( / ) and WT ﬁbroblasts responded
robustly when stimulated mechanically by a medium
change (Fig. 4 A). However, WT cells exhibited signiﬁ-
cantly higher extracellular ATP levels compared with
VDAC-1 ( / ) cells 2 and 10 min after medium
change. No differences were observed in basal extracel-
lular ATP levels. Intracellular ATP levels were not dif-
ferent between VDAC-1 ( / ) and WT cells (Fig. 4 B).
Hypotonicity-induced ATP Release from VDAC-1 ( / ) 
and WT Airway Epithelial Cells
Apical and basolateral surface liquids bathing well-dif-
ferentiated tracheal and nasal cultures were sampled
and ATP concentrations measured before and during
hypotonic challenge by two complementary methods,
luciferin-luciferase derived luminometry and etheno-
derivatization coupled to HPLC.
With luminometry, no differences in ATP concen-
trations were observed between VDAC-1 ( / ) and
WT tracheal cells in the basal (resting) state in either
the apical (Fig. 5 A) or basolateral (0.1   0.03 nM in
VDAC ( / ) and 0.11   0.02 nM in WT, three exper-
iments on three separate litters with n   4 transwells/
genotype/litter) liquids. 2 min after 10  l H2O was
gently added to the apical surface to generate a 66%
hypotonic challenge, a robust increase in ATP in api-
cal surface liquid was observed in WT cells, whereas
VDAC-1 ( / ) mouse cultures exhibited a smaller in-
crease in levels of released ATP (Fig. 5 A). Basolateral
bath ATP concentrations showed no change in re-
sponse to apical hypotonic challenge for either geno-
type ( ATP at 2 min   0.02   0.005 nM in VDAC-1
( / ) and 0.03   0.01 nM in WT, three experiments
on three separate litters with n   4 transwells/geno-
type/litter).
Based on the measurements with mouse tracheal
cells that (a) intracellular ATP was  1.8 nmol/well-dif-
ferentiated cells conﬂuent on a 6.5-mm transwell (Fig.
5 E,  20 nmol ATP/million cells    9   104 cells/
transwell); (b) the resting state ATP concentration as
microsampled was  1 nM, and was increased to  75
nM by hypotonic challenge (Fig. 5 A); and (c) apical
surface liquid was 30  l, our calculations demonstrated
that the amount of ATP released under basal and stim-
ulated conditions represented only 0.0017 and 0.12%
of intracellular ATP, respectively.
To control for the effect of the mechanical stress due
to liquid addition, isosmotic liquid (10  l mannitol) was
added to the apical surface, which had no effect on api-
Figure 3. Expression of pl-VDAC-1 and mt-VDAC-1 mRNA in
primary cultures from WT and VDAC-1 ( / ) mice. RNA was
prepared from 4-wk-old well-differentiated tracheal (T) and nasal
(N) cultures and lung ﬁbroblasts (F) for RT-PCR ampliﬁcation of
pl-VDAC-1 or mt-VDAC-1. Primer sets f-pl and r, and f-mt and r
were used to amplify pl-VDAC-1 and mt-VDAC-1, respectively.
Cyclophilin B mRNA was ampliﬁed as a housekeeping control.
Both pl-VDAC-1 and mt-VDAC-1 were detected from tracheal (T)
and nasal (N) cultures and from ﬁbroblasts (F) of WT mice. Bands
on the gel were extracted and the sequence was conﬁrmed for
each transcript. RT-PCR of RNA from VDAC-1 ( / ) cultures
exhibited no detectable VDAC transcripts.
Figure 4. Extracellular and intracellular ATP
levels from WT and VDAC-1 ( / ) mouse ﬁbro-
blasts. (A) Time course for ATP release after
medium change. Points represent mean,  SEM,
of experiments conducted on three separate litters
with n   4 transwells/genotype/litter. * indicates
signiﬁcant difference between WT ( ) and
VDAC-1 ( / ) ( ) mice at P   0.05. (B) Intra-
cellular ATP levels after extraction by TCA. Bars
represent mean,  SEM, of three litters with n   4
transwells/genotype/litter.519 Okada et al.
cal (Fig. 5 B) or basolateral (remained  0.2 nM at all
time points) surface liquid ATP levels for both geno-
types. In separate experiments, basolateral hypotonic
challenge (66%) caused increase in basolateral ATP lev-
els (5.2   0.5 fold in WT and 2.8   0.4 fold in VDAC-1
( / ), 2 min after hypotonic challenge, three experi-
ments on three separate litters with n   4 transwells/ge-
notype/litter) with no change in apical ATP levels.
Luminometry is highly sensitive. However, since ATP
is rapidly hydrolyzed by ecto-nucleotidases (Picher et
al., 2003), measurement of ATP alone could underesti-
mate the total amount of released ATP and lead to in-
accurate comparisons of ATP release between cell
populations with different cell surface ecto-nucleoti-
dase activities. Thus, the etheno-derivertization protocol,
which allowed us to quantitate all adenyl purine spe-
cies, was useful to estimate the total amount of released
ATP, irrespective of its conversion to ADP, AMP, and
adenosine. With etheno-derivertization, no differences
in basal accumulation of individual or total adenyl pu-
rine species were detected between VDAC-1 ( / )
and WT tracheal cultures (Fig. 5 D). However, 2 min af-
ter hypotonic challenge, an increased accumulation of
adenyl purines was observed in both VDAC-1 ( / )
and WT cells, but the accumulation of ATP, ADP, AMP,
and adenosine was greater in WT cells (Fig. 5 C). Intra-
cellular ATP levels were not different between VDAC-1
( / ) and WT mice cells (Fig. 5 E).
A proﬁle similar to that of tracheal cultures was ob-
served in nasal cultures: apical ATP concentrations
(nM) at stationary state were 1.5   0.3 in VDAC-1 ( / )
and 1.2   0.3 in WT; 2 min after hypotonic challenge,
apical ATP concentrations were 14.0   2.4 in VDAC-1
( / ) and 33.3   5.1 in WT (with luminometry, three
experiments on three separate litters with n   6 trans-
wells/genotype/litter). As in tracheal cells, intracellu-
lar ATP levels did not differ between the two groups of
nasal cells; 25.4   0.1 and 27.8   0.6 nmol/million
cells in VDAC-1 ( / ) and WT cells, respectively (with
luminometry, three litters with n   4 transwells/geno-
type/litter).
Role of ATP Release in Airway Epithelial Regulatory 
Volume Decrease
The observation that airway epithelial cells responded
to luminal hypotonic challenge with ATP release raised
the question as to the physiological relevance of hypo-
tonicity-induced ATP release and the role of pl-VDAC-1
in this physiology. Because a role for extracellular ATP
in facilitating regulatory volume decrease (RVD) after
hypotonic cell swelling via P2Y2 receptor–mediated Cl 
and K  channel activation has been reported in HTC
rat hepatoma cells (Wang et al., 1996b; Roman et al.,
1997; Feranchak et al., 1998), human intestine 407 cells
(Dezaki et al., 2000) and human cholangiocarcinoma
cells (Gatof et al., 2004), we investigated whether simi-
Figure 5. Extracellular ATP concen-
trations in the apical surface liquid of
tracheal cultures from WT and VDAC-1
( / ) mice after apical hypotonic
challenge. (A) Apical hypotonic chal-
lenge: H2O was added gently to the
apical surface at t   0 to generate a
200 mOsm solution, and samples were
collected from the apical solution at
each indicated time and analyzed by
luminometry. (B) Apical isosmotic
challenge: a 300 mOsm mannitol solu-
tion was added to the lumen at t   0
and samples obtained and processed as
in A. Points represent mean,  SEM,
of experiments conducted on three
separate litters with n   8 transwells/ge-
notype/litter. * indicates signiﬁcant
difference between WT ( ) and
VDAC-1 ( / ) ( ) mice (P   0.05).
(C and D) Proﬁle of adenyl purines in
the apical surface liquid covering (D)
basal (t    0) and (C) hypotonicity-
stimulated (2 min after challenge)
tracheal epithelia. Samples at each
point were analyzed by etheno-deriverti-
zation. Bars represent mean,  SEM, of
experiments conducted on three separate litters with n   12 transwells/genotype/litter. * indicates signiﬁcant difference between WT ( )
and VDAC-1 ( / ) ( ) mice (P   0.05). (E) Intracellular ATP levels determined after extraction by TCA. Bars represent mean,  SEM,
of three litters with n   4 transwells/genotype /litter.520 VDAC and ATP Release
lar mechanisms were present in mouse airway epithelia
and whether pl-VDAC-1 was involved.
Tracheal cells from FOXJ1/EGFP Transgenic Mice. Airway
epithelial cultures exhibit a complex phenotype with dif-
ferentiated surface cells, including ciliated cells and gob-
let cells, covering a single to several layers of basal cells.
To investigate the role of ATP release in epithelial cell
volume regulatory responses, we initiated studies with a
model system that allowed accurate measurements of
the volume responses of lumen-facing cells to luminal
hypotonicity. Well-differentiated tracheal cultures from
FOXJ1/EGFP transgenic mice that selectively express
EGFP in ciliated cells (Ostrowski et al., 2003) were used.
The height of each ﬂuorescent ciliated cell was mea-
sured by confocal microscopy before (t   0) and at des-
ignated times after dilution of the apical liquid to form
a hypotonic (200 mOsm) solution. Tracheal epithelial
cells exhibited a rapid increase in height after hypotonic
challenge (Fig. 6 A). This initial increase ( 25%) was
less than the expected level of volume increase (50%) if
these cells acted as perfect osmometers in response to
the dilution of apical liquid (300 to 200 mOsm) (Fig. 6
B). In comparison to previous reports describing the ab-
sence of regulatory volume increase (RVI) in human air-
way epithelia after hypertonic challenge (Willumsen et
al., 1994; Matsui et al., 2000), mouse airway cells exhib-
ited an RVD after hypotonic challenge.
To test the role of luminally released ATP in RVD, cul-
tures were pretreated with 10 U/ml apyrase (Fig. 6, A
and B). After this treatment, the initial swelling in re-
sponse to hypotonic challenge increased to a level
closer to the response of a perfect osmometer ( 40%).
Further, RVD was less effective in returning cell heights
to baseline. Conversely, when the cultures were exposed
to 100  M ATP with hypotonic challenge, the peak cell
height responses to hypotonic challenge decreased with
more rapid return to baseline cell height (Fig. 6, A and
B). Collectively, these data suggested a role for extracel-
lular ATP to facilitate the cell volume recovery during
and after luminal hypotonicity–induced cell swelling.
Tracheal Cells from VDAC-1 ( / ) and WT Mice. Hav-
ing demonstrated that ciliated cells undergo swelling
and RVD upon luminal hypotonic challenge, we next
addressed whether pl-VDAC-1 was involved in the pro-
cess. Well-differentiated tracheal cultures from VDAC-1
( / ) and WT mice were studied with the same proto-
col as used in FOXJ1/EGFP cultures, except that cells
were labeled with calcein-AM and cell volume change
measured as change of luminal cell height, deﬁned as
the distance from the transwell membrane to the top of
the cytoplasm (see materials and methods). Tracheal
epithelia from both genotypes exhibited increases in
cell height and RVD after hypotonic challenge (Fig. 7
A). The initial volume increase of tracheal cultures was
similar for VDAC-1 ( / ) and WT mice, but RVD was
consistently slower in VDAC-1 ( / ) cells (Fig. 7 B).
We speculated that the slower rate of RVD in VDAC-1
( / ) mouse tracheal cultures reﬂected the reduced
Figure 6. Hypotonicity-
induced swelling and regula-
tory volume decrease (RVD)
of tracheal cultures from
FOXJ1/EGFP transgenic mice
as measured by confocal mi-
croscopy. The cytosol of cili-
ated cells is deﬁned by green
ﬂuorescence due to the cili-
ated cell–speciﬁc FOXJ1-
driven expression of EGFP.
Bar, 10  m. (A) In the top
panels, at t    0, H2O was
added gently onto the apical
surface to generate 200 mOsm
of hypotonicity. In the middle
panels, cultures were preincu-
bated with apyrase (10 U/ml)
for 5 min, and H2O including
apyrase (10 U/ml) was gently
added to generate luminal
hypotonicity at time 0. In the
bottom panels, ATP (100  M)
was gently added together
with luminal H2O challenge at t   0. (B) Summary data for protocols illustrated in A. Points indicate mean relative tracheal cell
height compared with t   0, of cultures from two separate litters with n   4 transwells/genotype/litter. * indicates signiﬁcant difference
(P   0.05) of points for hypotonic challenge (H2O alone) group compared with t   0. † indicates signiﬁcant difference between hypotonic
challenge alone (white) and apyrase pretreatment (blue) P   0.05). ‡ indicates signiﬁcant difference between hypotonic challenge alone
and exogenous 100  M ATP addition (red) (P   0.05).521 Okada et al.
rate of ATP release, and hence, lower ATP concentra-
tion at the cell surface. Tests of this hypothesis included
whether an excess or an absence of ATP eliminated the
difference in RVD kinetics between VDAC-1 ( / )
and WT tracheal cells. As shown in Fig. 7 C, addition of
ATP to the lumen of VDAC-1 ( / ) and WT cultures
resulted in reduced initial cell height responses, and
importantly similar RVD kinetics, in both cell types.
Conversely, addition of apyrase to the lumen led to sim-
ilar increases in initial cell height, and again, similar ki-
netics of RVD in both cell types (Fig. 7 D). Thus, we
conclude that the response of both cell types to each
maneuver is similar, and hence, the differences in RVD
kinetics between VDAC-1 ( / ) and WT epithelia in
the absence of these maneuvers (Fig. 7 B) likely reﬂect
differences in ATP release rates.
DISCUSSION
Our experiments explored the potential relationship of
VDAC-1 to ATP release from murine cells. In a ﬁrst se-
ries of studies, this relationship was investigated in NIH
3T3 ﬁbroblasts. Functionally, greater ATP release was
observed from pl-VDAC-1–transfected ﬁbroblasts com-
pared with mock-transfected cells in response to me-
dium change 14 d after transfection (Fig. 2). Thus, it
appears that the ﬂow-induced shear stress induced by a
medium change interacted with pl-VDAC-1 to generate
ATP release. Of note, mock-transfected cells released
ATP, albeit in lower amounts, in response to medium
change, which may partially reﬂect endogenous pl-
VDAC-1 expression or other mechanisms of ATP re-
lease. The absence of differences in basal ATP levels
between pl-VDAC-1– and mock-transfected cells sug-
gests that pl-VDAC-1–independent mechanisms regulate
basal ATP release.
When pl-VDAC-1-myc–transfected ﬁbroblasts were
maintained in culture longer than 35 d after transfec-
tion, the enhanced ATP release after mechanical stress
was reduced in parallel with a decreased level of pl-
VDAC-1-myc expression (Fig. 2 B). This result may re-
ﬂect the cytotoxicity resulting from pl-VDAC-1 overex-
pression (Buettner et al., 2000), and the correlation of
pl-VDAC-1 protein expression levels and enhanced
ATP release levels argues for a role of pl-VDAC-1 in
ATP release.
As required for all studies of extracellular ATP
release, we investigated whether the higher rate of
Figure 7. Hypotonicity-
induced swelling and RVD
of WT and VDAC-1 ( / )
mouse tracheal epithelial
cultures measured in calcein-
AM–labeled cells with confo-
cal microscopy. (A) Represen-
tative time course for swelling
and RVD of (top) WT and
(bottom) VDAC-1 ( / )
tracheal cultures. At t    0,
H2O was added gently onto
the apical surface to generate
a 200 mOsm solution. Bar,
10   m. (B) Summary data
describing time course of cell
volume response to apical
hypotonic stimulus. * indi-
cates signiﬁcant difference
(P   0.05) between WT ( )
and VDAC-1 ( / ) ( ).
(C and D) Hypotonicity-
induced swelling and RVD
of WT and VDAC-1 ( / )
cultures with exogenous ad-
dition of (C) ATP or (D)
apyrase. The same protocol
for treatment and measure-
ment were used as in Fig. 6.
In B–D, points indicate per-
cent initial cell height. Each
point depicts the mean,
 SEM, of data from experi-
ments on three separate litters
with n   4 transwells/geno-
type/litter.522 VDAC and ATP Release
ATP release from pl-VDAC-1–transfected ﬁbroblasts re-
sulted from cell lysis, e.g., cell fragility due to pl-VDAC-1
transfection. However, from the morphological obser-
vations and cell viability assays, cell lysis was minimal
and not different between mock- and pl-VDAC-1–trans-
fected populations. These data, plus data demonstrat-
ing no effect of pl-VDAC-1 transfection on extracellular
ATP metabolism, led us to conclude that pl-VDAC-1
transfection conferred higher shear stress–induced
rates of ATP release from NIH 3T3 ﬁbroblasts.
As a second approach to address the role of pl-VDAC-1
in cellular ATP release, we used the VDAC-1 ( / )
mice model, which provided a null background for
both mt-VDAC-1 and pl-VDAC-1. In mice, three VDAC
genes (VDAC-1, VDAC-2, and VDAC-3) have been
identiﬁed that are 65–70% identical to one another
(Sampson et al., 1997). Targeted disruption of VDAC-1
exhibited a partial, strain-speciﬁc embryonic lethality,
whereas VDAC-2 ( / ) embryos were nonviable and
VDAC-3 ( / ) mice were viable (Anﬂous et al., 2001;
Sampson et al., 2001; Weeber et al., 2002; Cheng et al.,
2003). The lethality of VDAC-2 disruption is explained
by its function as a component of the mitochondrial
permeability transition pore that participates in apop-
totic and necrotic cell death (Cheng et al., 2003).
VDAC-1 ( / ) mice of viable strains exhibited altered
mitochondrial ADP translocation into mitochondria in
striated muscles (ventricle, soleus, and gastrocnemius)
(Anﬂous et al., 2001) as well as disrupted fear condi-
tioning and spatial learning (Weeber et al., 2002). The
reason why lethality of VDAC-1 is only partial, despite
the facts that it is the most abundant isoform and plays
a critical role in maintaining cellular homeostasis by
transporting purine metabolites across mitochondrial
outer membrane, may be explained by redundancy. In
support of this notion, we found that the intracellular
ATP concentrations in ﬁbroblasts and tracheal/nasal
epithelia grown in vitro were not affected by VDAC-1
deﬁciency (Fig. 4 B and Fig. 5 E).
Hypotonic challenge, which induces membrane shear
stress secondary to membrane expansion, is an effec-
tive stimulus for ATP release from various epithelia
(Wang et al., 1996a; Hazama et al., 1999). Hypotonic
challenge of the lumen of tracheal and nasal epithelia
greatly increased the ATP concentrations in the lumi-
nal liquid bathing WT cultures without affecting the
ATP concentration of the basolateral baths (Fig. 5 A).
The levels of ATP in the luminal liquid of VDAC-1 ( / )
cultures after a hypotonic challenge were reduced
by  50% compared with WT cultures, in both lumi-
nometry and etheno-derivertization, suggesting a true
reduction in ATP release from VDAC-1 ( / ) cultures
rather than a difference in ectonucleotidase activities
(Fig. 5, A and C). The observation that the intracellular
ATP levels in VDAC-1 ( / ) cells were similar to WT
cells (Fig. 5 E) argued against the possibility that de-
creased ATP release from VDAC-1 ( / ) cells reﬂected
a decreased chemical driving force resulting from de-
creased intracellular ATP concentrations. Thus, we
conclude that VDAC-1 contributes to hypotonicity-
induced ATP release into apical surface liquid in WT
mouse airway epithelia.
Several possible mechanisms may mediate the con-
tribution of VDAC-1 to ATP release. It is possible
that VDAC-1 itself serves as a plasmalemmal ATP re-
lease channel. Our calculations demonstrated that the
amount of ATP released under basal and stimulated
conditions represented only 0.0017 and 0.12% of intra-
cellular ATP, respectively. This rate of release may re-
quire no more than a few active channels/cell and,
likely, would not be cytotoxic to cells. It is also possible
that VDAC could regulate the activity of ATP release
molecules within the plasma membrane. Alternatively,
VDAC-1 may not need to localize on plasma membrane
to regulate ATP release. However, our data argue that
VDAC-1 does not affect ATP release by regulating intra-
cellular ATP concentration and hence altering the
chemical driving force for translocation (Fig. 4 B and
Fig. 5 E).
We should note that VDAC-1 ( / ) airway epithelia
and ﬁbroblasts exhibited basal ATP levels similar to
those of WT cells and released  50% less, but signiﬁ-
cant, amounts of ATP in response to stimuli. These
ﬁndings suggest that VDAC-1 ( / ) cells have mecha-
nisms for basal and stimulated ATP release indepen-
dent from VDAC-1. Future studies are required to as-
sess whether these mechanisms involve other VDAC-
like channels, transporters, or as suggested by recent
studies, vesicular exocytosis of ATP (Knight et al., 2002;
Schwiebert et al., 2002; van der Wijk et al., 2003; Gatof
et al., 2004).
The interaction of extracellular ATP with purinore-
ceptors facilitates RVD after hypotonic cell swelling in
various cell types (Hwang et al., 1996; Gatof et al.,
2004). Based on the ﬁnding that VDAC-1 ( / ) air-
way cells released  50% less ATP compared with WT
cells in response to hypotonic challenge, we investi-
gated the role of ATP release in cellular swelling and
RVD in mouse airway epithelia. Data derived from
EGFP-expressing ciliated cells, which allowed for the
most accurate measurement of changes in cell height,
revealed that mouse airway cells responded to hypo-
tonic challenge with cell swelling (Fig. 6 A). Impor-
tantly, confocal microscopy conﬁrmed that the cellular
responses to luminal hypotonicity were initial swelling
and subsequent RVD, not irreversible cell lysis, support-
ing the concept that ATP release after hypotonic chal-
lenge did not reﬂect cytolytic release. The data from
these cells were consistent with a role for released ATP
both in regulating the height of the apparent initial in-523 Okada et al.
crease in cell height and the magnitude of RVD. For ex-
ample, the initial height change in response to hypo-
tonic challenge was less ( 25%; Fig. 6 B) than pre-
dicted if the apical membrane water permeability were
limiting (50%; Matsui et al., 2000). The addition of apy-
rase or ATP increased or reduced the initial cell height
change, respectively (Fig. 6 B). These data suggest that
the mouse airway epithelial volume response to lumi-
nal hypotonicity is mediated by two mechanisms. First,
the initial cell swelling reﬂects the movement of water
into the cell across the highly water-permeable apical
membrane in response to the imposed osmotic gradi-
ent (Matsui et al., 2000). Second, there is a component
of cell volume regulation that is mediated by loss of cel-
lular osmotic content. This latter response is mediated
by ATP release and activation of P2Y2 receptors. P2Y2
receptors, via increase in intracellular Ca2  and possi-
bly protein kinase C   activation (Hermoso et al.,
2004), activate both apical Cl  and K  channels to re-
lease KCl into the apical medium, which produces RVD
(Clarke and Boucher, 1992; Clarke et al., 1997; Ho-
molya et al., 1999; Okada et al., 2001; Darby et al.,
2003). This second component (ATP-mediated KCl
movement) is likely to occur simultaneously with water
movement into the cell, resulting in smaller than theo-
retical initial cell height increase (i.e.,  25 compared
with 50%).
The role of VDAC-1 in the ATP signaling compo-
nent of hypotonicity-induced RVD was investigated in
VDAC-1 ( / ) cultures. The initial swelling of tra-
cheal or nasal epithelia in response to hypotonicity was
similar for VDAC-1 ( / ) and WT mice, but the recov-
ery from the peak of swelling (“RVD phase”) was mark-
edly slower in VDAC-1 ( / ) cells than in WT cells
(Fig. 7 B). The observations that VDAC-1 ( / ) cells
(a) did not exhibit detectably larger initial swelling re-
sponses than WT cells and (b) responded to apyrase
treatment with an increased peak cell height and a
slower RVD (Fig. 7 D) may reﬂect the partial ATP re-
lease in VDAC-1 ( / ) cultures in response to hypoto-
nicity (Fig. 5 A). When extracellular ATP levels were
pharmacologically reduced or increased by addition of
apyrase or ATP, respectively, VDAC-1 ( / ) and WT
cells exhibited similar peak cell height response and
RVD in response to hypotonic challenge (Fig. 7, C and
D). From these data, we conclude that VDAC-1 plays a
physiological role in the RVD response to luminal hy-
potonicity by mediating luminal extracellular ATP
release.
It is important to note that not all species may have a
putative plasmalemmal splice variant of VDAC. Mouse
and human VDAC-1s are 98% identical at the amino
acid level. However, bioinformatics sequence analyses
have not identiﬁed a pl-VDAC-1 splice site in the hu-
man gene. We attempted to identify such a splice vari-
ant isoform of human mitochondrial VDAC-1 by 5 -
RACE-PCR, but 100 out of 100 clones isolated were iden-
tical to mitochondrial VDAC-1, without a coding se-
quence for the NH2-terminal signal peptide expected for
plasmalemmal VDAC-1. Thus, the role of pl-VDAC-1 in
ATP release in murine cells may be served by other pro-
teins in humans. It is, however, possible that mt-VDAC-1
is expressed also in the plasma membrane in humans.
Recent biochemical observations suggest the expression
of VDAC-1 (identical to the mitochondrial form) in the
plasma membranes of human endothelial cells (Gonza-
lez-Gronow et al., 2003) and human B lymphocytes
(Baker et al., 2004). Thus, we cannot distinguish amongst
the hypotheses that human airway epithelia (a) do not
express VDAC-1 or a related protein at the plasma mem-
brane; (b) some mt-VDAC-1 enters the secretory pathway
to reach the plasma membrane and mediate ATP release;
or (c) a related VDAC-like protein is expressed at the
plasma membrane and mediates ATP release.
In summary, we conclude that VDAC-1 contributes to
ATP transport across the plasma membrane of murine
cells. Studies of pl-VDAC-1 overexpression in NIH 3T3
cells produced evidence for both increased ATP release
in response to mechanical stimuli. Studies of airway ep-
ithelial cells from VDAC-1–deﬁcient mice revealed re-
duced ATP release and reduced ATP-mediated cell vol-
ume responses to luminal hypotonicity as compared
with littermate controls. Our studies do not resolve the
issue of whether VDAC-1 exerts those activities by being
expressed at the plasma membrane as maxi-anion
channels, via regulation of vesicular exocytosis, or as a
regulator of other ATP transport proteins. Further, our
data suggest that molecules other than VDAC are in-
volved in basal ATP release and a component ( 50%)
of stress-induced ATP release. However, our studies
ruled out other explanations to account for reduced
extracellular ATP levels in VDAC-1 ( / ) cells, e.g.,
reduced intracellular ATP concentrations, facilitated
extracellular ATP hydrolysis, or decreased cell lysis.
Thus, our data argue that VDAC-1 protein is a candi-
date molecule to control the release of ATP into the ex-
tracellular environment of murine cells.
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